SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank21
3Y CAGR-18.2%
5Y CAGR-8.3%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
-18.2%/yr
Annual compound
5Y CAGR
-8.3%/yr
Recent deceleration
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
20258.42%
202410.51%
202313.53%
202215.39%
20212.01%
202012.98%
201910.03%
2018-15.63%
201711.38%
20162.62%